8-K/A XBRL

FORM 8-K/A

Company: Moleculin Biotech, Inc.
Filed: August 23, 2023
Period of Report: August 21, 2023
Accession Number: 0001437749-23-024528

View Document ↗ View on SEC.gov ↗